CN106132405B - N,n-二-2-巯基乙基异邻苯二甲酰胺的用途 - Google Patents
N,n-二-2-巯基乙基异邻苯二甲酰胺的用途 Download PDFInfo
- Publication number
- CN106132405B CN106132405B CN201580017210.4A CN201580017210A CN106132405B CN 106132405 B CN106132405 B CN 106132405B CN 201580017210 A CN201580017210 A CN 201580017210A CN 106132405 B CN106132405 B CN 106132405B
- Authority
- CN
- China
- Prior art keywords
- nbmi
- group
- patient
- cell
- exposure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1406115.4 | 2014-04-04 | ||
| GB1406115.4A GB2524831A (en) | 2014-04-04 | 2014-04-04 | New pharmaceutical use |
| PCT/GB2015/050999 WO2015150793A1 (en) | 2014-04-04 | 2015-03-31 | New use of n,n-bis-2-mercaptoethyl isophthalamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106132405A CN106132405A (zh) | 2016-11-16 |
| CN106132405B true CN106132405B (zh) | 2019-06-18 |
Family
ID=50776843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201580017210.4A Active CN106132405B (zh) | 2014-04-04 | 2015-03-31 | N,n-二-2-巯基乙基异邻苯二甲酰胺的用途 |
Country Status (36)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202005057D0 (en) * | 2020-04-06 | 2020-05-20 | Emeramed Ltd | New Use |
| CN114778234B (zh) * | 2022-03-18 | 2025-08-15 | 武汉新烽光电股份有限公司 | 一种用于微流控总磷测试的抗坏血酸溶液的保存方法及保存结构 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100227812A1 (en) * | 2008-12-06 | 2010-09-09 | Haley Boyd E | Method of supplementing the diet and ameliorating oxidative stress |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586600B2 (en) * | 2000-12-06 | 2003-07-01 | University Of Kentucky Research Foundation | Multidentate sulfur-containing ligands |
| JP2011026204A (ja) * | 2007-11-26 | 2011-02-10 | Rei Furukawa | タバコの煙を吸入することにより引き起こされる疾患の予防及び／又は治療用組成物 |
| RU2528396C2 (ru) * | 2009-09-28 | 2014-09-20 | Юнивёрсити Оф Кентукки Рисёч Фаундейшн | Тиолсодержащие соединения для удаления элементов из загрязненной окружающей среды и способы их применения |
| US8575218B2 (en) | 2009-09-28 | 2013-11-05 | The University Of Kentucky Research Foundation | Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| US20110237776A1 (en) | 2010-03-25 | 2011-09-29 | Haley Boyd E | Aromatic compounds with sulfur containing ligands |
| US8426368B2 (en) * | 2010-03-25 | 2013-04-23 | The University Of Kentucky Research Foundation | Method of ameliorating oxidative stress and supplementing the diet |
-
2014
- 2014-04-04 GB GB1406115.4A patent/GB2524831A/en not_active Withdrawn
-
2015
- 2015-03-31 PT PT157235466T patent/PT3125876T/pt unknown
- 2015-03-31 HR HRP20180325TT patent/HRP20180325T1/hr unknown
- 2015-03-31 SM SM20180116T patent/SMT201800116T1/it unknown
- 2015-03-31 UA UAA201611073A patent/UA119558C2/uk unknown
- 2015-03-31 MX MX2016012591A patent/MX2016012591A/es active IP Right Grant
- 2015-03-31 EA EA201692013A patent/EA032116B1/ru unknown
- 2015-03-31 SG SG11201607478RA patent/SG11201607478RA/en unknown
- 2015-03-31 NO NO15723546A patent/NO3125876T3/no unknown
- 2015-03-31 DK DK15723546.6T patent/DK3125876T3/en active
- 2015-03-31 RS RS20180210A patent/RS56905B1/sr unknown
- 2015-03-31 CN CN201580017210.4A patent/CN106132405B/zh active Active
- 2015-03-31 EP EP15723546.6A patent/EP3125876B8/en active Active
- 2015-03-31 ME MEP-2018-50A patent/ME03012B/me unknown
- 2015-03-31 PE PE2016001785A patent/PE20170586A1/es unknown
- 2015-03-31 US US15/129,654 patent/US9782368B2/en active Active
- 2015-03-31 ES ES15723546.6T patent/ES2659174T3/es active Active
- 2015-03-31 PL PL15723546T patent/PL3125876T3/pl unknown
- 2015-03-31 CA CA2944113A patent/CA2944113C/en active Active
- 2015-03-31 WO PCT/GB2015/050999 patent/WO2015150793A1/en not_active Ceased
- 2015-03-31 LT LTEP15723546.6T patent/LT3125876T/lt unknown
- 2015-03-31 KR KR1020167030801A patent/KR102482699B1/ko active Active
- 2015-03-31 HU HUE15723546A patent/HUE036206T2/hu unknown
- 2015-03-31 NZ NZ724678A patent/NZ724678A/en unknown
- 2015-03-31 MA MA39833A patent/MA39833B1/fr unknown
- 2015-03-31 BR BR112016022880-4A patent/BR112016022880B1/pt active IP Right Grant
- 2015-03-31 JP JP2016557313A patent/JP6474423B2/ja active Active
- 2015-03-31 SI SI201530158T patent/SI3125876T1/en unknown
- 2015-03-31 AU AU2015242374A patent/AU2015242374B2/en active Active
-
2016
- 2016-09-16 ZA ZA2016/06406A patent/ZA201606406B/en unknown
- 2016-09-25 IL IL248027A patent/IL248027B/en active IP Right Grant
- 2016-09-30 CL CL2016002499A patent/CL2016002499A1/es unknown
- 2016-09-30 EC ECIEPI201678100A patent/ECSP16078100A/es unknown
- 2016-10-01 SA SA516371966A patent/SA516371966B1/ar unknown
- 2016-10-04 PH PH12016501975A patent/PH12016501975A1/en unknown
-
2018
- 2018-02-09 CY CY20181100160T patent/CY1121235T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100227812A1 (en) * | 2008-12-06 | 2010-09-09 | Haley Boyd E | Method of supplementing the diet and ameliorating oxidative stress |
Non-Patent Citations (3)
| Title |
|---|
| Antioxidant therapeutic advances in COPD;Irfan Rahman;《Therapeutic Advances in Respiratory Disease》;20081231;第2卷(第6期);第351-374页 * |
| Rishi B. Patel等.Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N’-bis-2-mercap.《TOXICOLOGY MECHANISMS AND METHODS》.2012,第22卷(第5期),第383-396页. * |
| Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N’-bis-2-mercap;Rishi B. Patel等;《TOXICOLOGY MECHANISMS AND METHODS》;20120630;第22卷(第5期);第383-396页 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Solinas et al. | A critical evaluation of glucocorticoids in the management of severe COVID-19 | |
| Kim et al. | Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation | |
| Bresciani et al. | Rhinosinusitis in severe asthma | |
| Serrano et al. | Guidelines for severe uncontrolled asthma | |
| Yang et al. | Nerve growth factor exacerbates allergic lung inflammation and airway remodeling in a rat model of chronic asthma | |
| Mekonnen et al. | A review of upper airway physiology relevant to the delivery and deposition of inhalation aerosols | |
| Lamblin et al. | Long-term follow-up of pulmonary function in patients with nasal polyposis | |
| CN106132405B (zh) | N,n-二-2-巯基乙基异邻苯二甲酰胺的用途 | |
| Lin et al. | Cough responses to inhaled irritants are enhanced by eosinophil major basic protein in awake mice | |
| Erel et al. | Serum leptin levels and lipid profiles in patients with allergic rhinitis and mild asthma | |
| Choi et al. | Subchronic inhalation toxicity study of 3R4F reference cigarette smoke in rats | |
| Ruihong et al. | Effect of terbutaline combined with budesonide in treatment of bronchial asthma and rehabilitation nursing. | |
| Kuch et al. | Local effects of two intravenous formulations of pulmonary vasodilators on airway epithelium | |
| Saillaja | An overall review on chronic asthma | |
| HK1228798A1 (en) | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
| HK1228798B (en) | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
| Bassam et al. | Steroids in asthma: friend or foe | |
| Xie et al. | Specific Immunotherapy and Follow-up Management of Respiratory Allergic Diseases in Children. | |
| Shomar | Progesterone and Estrogen Influence Baseline Breathing Parameters and Chemoreflexes in Menstruating Women | |
| Nikniaz et al. | The effect of aerobic exercise and vitamin D supplementation on inflammatory factors, anti-inflammatory proteins, and lung function in male smokers: A randomized controlled trial | |
| Mujawar | A Study to Assess the Effectiveness of Arsenicum Album 30 in the Treatment of Bronchial Asthma by Using Peak Flow Meter | |
| D'Urzo et al. | Research Abstracts Presented at the 36th Annual Scientific Session of the Western Society of Allergy and Immunology. Part I | |
| Hema et al. | Effectiveness of Nebulisation with Oxygen and without Oxygen in Improving the Respiratory Status of Children with Wheezing at PESIMSR Hospital, Kuppam, Chittoor District, AP | |
| Hornstrup et al. | Changes in Brachial and Central Blood Pressure after Short Term Continuous Positive Airway Pressure Treatment of Patients with Moderate-to-Severe Obstructive Sleep Apnoea and Impaired Renal Function | |
| Reid et al. | Animal Model Selection for Inhalational HCN Exposure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |